CGB 0.00% 2.1¢ cann global limited

Ann: Queensland Bauxite Shareholder Q and A, page-43

  1. 4,287 Posts.
    lightbulb Created with Sketch. 452
    Your story sounds a lot like mine Pack!

    And you are right when you sell you can look at the big picture with a clear open mind and that doesn’t just apply to QBL but all stocks. The lesson is really to not fall in love with any stock. There’s gains to be made everywhere. If your boxes aren’t getting ticked then put your money in places where it is and yeah you can return to a stock when it does. I bought here straight after they first acquired MCL 55%. Sold out not long after legalised hemp for very similar reason to yours and have followed ever since. Lots of people get to attached to a stock! When you get over that and the whole long term view (there are those that are long term) in a penny and play the market and also look at the real fundamentals with a real open mind it all becomes so much easier. Holders hate the contrarian view but the company becomes better for them. Consider the dropping of Medcan employee profiles and what happened there. Will they do that again without doing their due diligence? Hopefully not. Who brought it to their attention.. someone here.. ultimately as a result their practices should improve from that experience. You would hope! And that’s not accusing the guy but more pointing the finger at the company for not being sure when there’s much at stake... that whole side of the business relies on licences otherwise it won’t work.

    I’m glad you pulled at 6c and made a profit and I’m happy you can see the bigger picture and if both of us get back into this stock it’s cause They have improved their practices and rebuilt trust.

    And big Dan remember you saying Red tractors hulled hemp was from QBL.. read the Q&A. It clearly isn’t.
    Last edited by 4hrworkweek: 13/07/18
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.